The World Health Organisation (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a critical tool for safely administering WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) malaria.
Trending
- Karibi-George wins Miss world Nigeria 2026
- Cui wins boys’ singles at 2026 NASCO/ITF J30 junior tennis in Abuja
- Fire destroys Iyanu plastic store in Osogbo, property worth millions lost
- NCC supports girls in ICT with industry excursion for 185 students
- Over 31,700 Katsina indigenes benefit from Lado scholarship (2023–2026)
- AIICO wins top award at 2026 Nairametrics capital market awards
- Stella heart foundation launches youth substance abuse campaign
- Nigeria to use €59m WASOP to fight illegal fishing
